Trastuzumab Emtansine for Injection

In clinical practice, trastuzumab emtansine injection refers to trastuzumab emtansine injection, which is a targeted therapy for HER-2 positive breast cancer patients. It can be used simultaneously with chemotherapy drugs or alone.

Trastuzumab emtansine injection is an antibody-drug conjugate targeting HER-2. It can inhibit HER-2 receptor signals, exert antibody-dependent cell-mediated cytotoxicity, inhibit human breast cancer cells that overexpress HER-2, and the shedding of the HER-2 extracellular domain, prevent the proliferation and growth of cancer cells, and promote the body’s own immune response, enhance the resistance of tumor cells, and improve the cure rate.

Trastuzumab emtansine injection is mainly suitable for breast cancer and gastric cancer patients who highly express HER-2 receptors, especially for the treatment of primary and metastatic breast cancer. In addition, it can also be used in combination with chemotherapy drugs such as paclitaxel injection according to the doctor’s advice to enhance the effect of chemotherapy and improve the cure rate.

However, it should be noted that patients may experience hepatotoxicity and liver failure after taking the medicine. Liver function should be monitored before starting the medicine and each time the medicine is taken, and the doctor should adjust the dose according to the situation.